FDA sends warning letter to literal snake oil salesman
NutraPharma claimed its cobra venom products could treat chronic pain for conditions ranging from cancer to addiction.
Regulatory
National Cancer Institute head named acting FDA commissioner
FDA Commissioner Scott Gottlieb said last Tuesday that he’s planning to resign in a few weeks.
What’s next for FDA? Four areas where the agency will have to fill a Gottlieb-sized void
What’s waiting on the desk of the next FDA commissioner.
Reports: Purdue weighs Chapter 11
The drugmaker is facing thousands of lawsuits saying the company contributed to the opioid crisis.
Expect legislative baby steps, not big leaps on drug prices
Even though both parties agree on lowering drug prices, experts predict changes will be incremental.
4 takeaways from Tuesday’s Senate drug pricing hearing
Seven pharma executives were grilled on drug prices on Capitol Hill on Tuesday.
Live blog: Pharma execs on the Hill
The latest from the Senate Finance Committee’s grilling of pharma executives on Capitol Hill.
What to watch: Congress to grill pharma CEOs over drug prices Tuesday
Seven top pharma executives are set to testify in front of lawmakers.
Was President Trump’s plan to reduce drug prices DOA?
President Trump’s blueprint to lower drug prices hasn’t made it out of the brainstorm phase.
Texas ACA ruling could reverberate across healthcare
Texas Judge Reed O’Connor’s ruling on the ACA could affect both insurers and pharma.
Want to read more?
Please login or register first to view this content.
